Sage Journals: Discover world-class research

Retricted access

Research article

First published 2017-10

Lixisenatide: A New Option for Managing Type 2 Diabetes

Jonathan S. Newsome

Journal of Pharmacy Technology

Free access

Review article

First published 2016-1

Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness

Sarah L. Anderson, Jennifer M. Trujillo

Sage Open Chronic Disease

Free access

Research article

First published 2014-1

Comparative Assessment of Lixisenatide,Exenatide,and Liraglutide Pen Devices

Udo Stauder, Diplom Enginee, Hina Elton [...]

Journal of Diabetes Science and Technology

Retricted access

Review article

First published 2017-5

Lixisenatide: A New Daily GLP-1 Agonist for Type 2 Diabetes Management

Delilah McCarty, Megan Coleman, Cassie L. Boland

Annals of Pharmacotherapy

Retricted access

Review article

First published 2017-11

iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 Diabetes

Jennifer Goldman, Jennifer M. Trujillo

Annals of Pharmacotherapy

Retricted access

Research article

First published 2017-1

Lixisenatide

Danial E. Baker, Terri L. Levien

Hospital Pharmacy

Free access

Research article

First published 2021-3

The Differential and Combined Action of Insulin Glargine and Lixisenatide on the Fasting and Postprandial Components of Glucose Control

Thibault Gautier, Guillermo Umpierrez, Eric Renard [...]

Journal of Diabetes Science and Technology

Retricted access

Review article

First published 2019-8

Combined Insulin and GLP-1 Receptor Agonists: Simplifying Treatment or Adding Obstacles?

Tianrui Yang, B. Tate Cutshall, Alexandra Tatara [...]

Journal of Pharmacy Practice

Open access

Research article

First published 2022-3

Modeling the Effect of Subcutaneous Lixisenatide on Glucoregulatory Endocrine Secretions and Gastric Emptying in Type 2 Diabetes to Simulate the Effect of iGlarLixi Administration Timing on Blood Sugar Profiles

Thibault Gautier, Rupesh Silwal, Aramesh Saremi [...]

Journal of Diabetes Science and Technology

Free access

Review article

First published 2014-10

Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making

Gerhard H. Scholz, Holger Fleischmann

Therapeutic Advances in Endocrinology and Metabolism

Search results